Balance Sheet

v3.25.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2024
Jun. 30, 2024
Current assets    
Cash $ 406,347 $ 661,415
Accounts receivable, net 1,161,606 606,885
Inventory, net 2,236,429 1,431,556
Due from VitaMedica transition 0 212,358
Prepaid expenses and other receivables 305,537 502,188
Assets available for sale - Building 0 4,005,516
Purchase price receivable - VitaMedica 2,000,000 2,000,000
Purchase price receivable - E-core 0 2,000,000
Total current assets 6,109,919 11,419,918
Property and equipment, net 2,140,452 2,356,556
Intangible assets, net 201,491 239,871
Goodwill 848,854 848,854
Deferred tax asset 5,948,858 5,948,858
Other assets 199,893 278,435
Right-of-use asset, net 2,079,782 2,418,596
Total other assets 11,419,330 12,091,170
Total assets 17,529,249 23,511,088
Current liabilities    
Accounts payable 1,004,770 481,647
Accrued compensation 837,650 1,098,856
Deferred revenue 138,961 235,255
Accrued liabilities 222,148 736,407
Accrued interest 629,661 476,018
Acquisition payable 413,152 413,152
Related party advances, net 0 100,000
Current portion of note payable 280,000 0
Current portion of convertible notes payable 775,000 0
Current portion of related party note payable 250,000 0
Current portion of Cygnet subsidiary notes payable 5,447,565 5,447,565
Note payable on building for sale 0 2,634,538
Current portion of operating lease payable 618,220 1,031,714
Total current liabilities 10,617,127 12,655,152
Operating lease payable, net of current portion 1,844,232 1,732,606
Related party note payable 250,000 500,000
Note payable 280,000 557,429
Convertible notes payable 775,000 1,550,000
Notes payable - Cygnet subsidiary 0 0
Total long-term liabilities 3,149,232 4,340,035
Stockholders' equity    
Preferred stock, $0.001 par value, 100,000,000 shares authorized, and 25,000 and 25,000 shares issued and outstanding, respectively 25 25
Common stock, $0.001 par value, 100,000,000 shares authorized, and 1,045,429 and 1,045,429 shares issued and outstanding, respectively 1,045 1,045
Additional paid in capital 53,548,320 53,374,444
Accumulated deficit (49,786,500) (46,859,613)
Total stockholders' equity attributable to Upexi, Inc. 3,762,890 6,515,901
Total stockholders' equity 3,762,890 6,515,901
Total liabilities and stockholders' equity $ 17,529,249 $ 23,511,088

Source

PDF HTML
ZIP